Log In
Print this Print this

masilukast (MCC-847) (formerly ZD-3523)

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionLeukotriene D4 antagonist
Molecular Target Leukotriene D4 receptor (LTD4)
Mechanism of ActionLeukotriene D4 antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAsthma
Indication DetailsTreat mild to moderate asthma
Regulatory Designation
PartnerSama Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today